New diagnostic method for Alzheimer’s disease based on the toxic conformation theory of amyloid β
Author:
- 20 September 2019
- journal article
- review article
- Published by Taylor & Francis in Bioscience, Biotechnology, and Biochemistry
- Vol. 84 (1) , 1-16
Abstract
Recent investigations suggest that soluble oligomeric amyloid β (Aβ) species may be involved in early onset of Alzheimer’s disease (AD). Using systematic proline replacement, solid-state NMR, and ESR, we identified a toxic turn at position 22 and 23 of Aβ42, the most potent neurotoxic Aβ species. Through radicalization, the toxic turn can induce formation of the C-terminal hydrophobic core to obtain putative Aβ42 dimers and trimers. Synthesized dimer and trimer models showed that the C-terminal hydrophobic core plays a critical role in the formation of high molecular weight oligomers with neurotoxicity. Accordingly, an anti-toxic turn antibody (24B3) that selectively recognizes a toxic dimer model of E22P-Aβ42 was developed. Sandwich enzyme-linked immunosorbent assay with 24B3 and 82E1 detected a significantly higher ratio of Aβ42 with a toxic turn to total Aβ42 in cerebrospinal fluid of AD patients compared with controls, suggesting that 24B3 could be useful for early onset of AD diagnosis. PKC C1 domains and various Aβ42 peptides could be synthesized effectively on PioneerTM. This synthetic technology is the foundation of this research.Keywords
Funding Information
- Japan Society for the Promotion of Science (11660109, 16380080, 13460048, 17H06405, 23102011, 19H00921, 26221202, 21258015, 18208011)
This publication has 114 references indexed in Scilit:
- Monoclonal Antibody Against the Turn of the 42-Residue Amyloid β-Protein at Positions 22 and 23ACS Chemical Neuroscience, 2010
- Structure–neurotoxicity relationships of amyloid β-protein oligomersProceedings of the National Academy of Sciences, 2009
- Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's diseaseNature Chemistry, 2009
- A cellular model of Alzheimer's disease therapeutic efficacy: PKC activation reverses Aβ-induced biomarker abnormality on cultured fibroblastsNeurobiology of Disease, 2009
- Total synthesis of bryostatin 16 using atom-economical and chemoselective approachesNature, 2008
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memoryNature Medicine, 2008
- Convergent Assembly of Highly Potent Analogues of Bryostatin 1 via Pyran Annulation: Bryostatin Look-Alikes That Mimic Phorbol Ester FunctionJournal of the American Chemical Society, 2008
- PKCε increases endothelin converting enzyme activity and reduces amyloid plaque pathology in transgenic miceProceedings of the National Academy of Sciences, 2006
- Taxonomy and function of C1 protein kinase C homology domainsProtein Science, 1997
- Crystal structure of the Cys2 activator-binding domain of protein kinase Cδ in complex with phorbol esterCell, 1995